Viimane versioon :
18/04/2024
Antibiootikum   Vancomycin hydrochloride  
Silmatilgad
Süsteravim Suukaudne lahus
Stabiilsust ravimpreparaadid Stabiilsust mõjutavad tegurid Stabiilsust mõjutavad faktorid Sobimatus Viited Pdf
   Keemiline struktuur  

Silmatilgad
Viited   Silmatilgad   Viited : Vancomycin hydrochloride  
Tüüp Avaldamine
2420 Ajaleht Fuhrman LC, Jr, RT Stroman
Stability of vancomycin in an extemporaneously compounded ophthalmic solution
Am J Health-Syst Pharm 1998 ; 55: 1386-1388
2649 Ajaleht Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J.
Impact of deep freezing on the stability of 25 mg/ml vancomycin ophtalmic solutions.
Int J Pharm 2002 ; 234, 1-2: 205-212.
2732 Ajaleht Barbault S, Aymard G, Feldman D, Pointereau-Bellanger A, Thuillier A.
Stability of vancomycin eye drops.
J Pharm Clin 1999 ; 18: 183-189.
4264 Ajaleht Karampatakis V, Papanikolaou T, Giannousis M, Goulas A, Mandraveli K, Kilmpasani M, Alexiou-Daniel S, Mirtsou-Fidani V.
Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
Acta Ophtalmol 2008
4596 Ajaleht Roura-Turet J, Rodriguez-Reyes M, Guerrero-Molina L, Soy-Muner D, López-Cabezas C.
Stability of 5% vancomycin ophthalmic solution prepared using balanced salt solution after freezing for 90 days.
Am J Health-Syst Pharm 2021 ;78,15:444–1447
4681 Ajaleht Chen P, Mar Z, Giannetti A, Hughes S, Gilbert J, Zhao F.
An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding.
Hosp Pharm 2022 ; 57, 1: 69-75.

  Mentions Légales